Research Article
Safety Assessment of High- and Low-Molecular-Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data
| Early-onset AEs (<72 hrs) | Late-onset AEs (>72 hrs) |
| (i) Injection site reactions: edema, pain, erythema, itching, bleeding, ecchymosis | (i) Late infection: biofilm and fibrosis (ii) Inflammatory nodule or granuloma | (ii) Displacements: lumps, asymmetries, contour deformities | (iii) Noninflammatory nodule | (iii) Hypersensitivity reaction | (iv) Altered pigmentation (v) Scarring | (iv) Early acute infection: HSV, abscess, cellulitis | | (v) Tyndall effect | | (vi) Thromboembolism | |
|
|